Nanobiotix S.A.
NBTX | NASDAQ
$34.69
+$0.19 (+0.55%)
Sep 22, 2026, 12:18 PM ET · Market open
TTM Period Ending | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 52.75M | 28.82M | 49.74M | 66.34M | 75.28M | 21.63M | 41.39M | 63.02M | 83.92M | 102.34M | 119.15M | 26.59M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 1K | n/a | 352K | 98K | 88K | 105K | 58K |
Other Long-Term Assets | 434K | 659K | 406K | 463K | 299K | -1K | 291K | 292K | 421K | 410K | 400K | 407K |
Receivables | 7.68M | 1.84M | 8.54M | 3.12M | 9.5M | 2.84M | 2.84M | 238K | 6.93M | 2M | 3.88M | 1.42M |
Inventory | n/a | n/a | n/a | n/a | n/a | 2.24M | 2.98M | 1.43M | n/a | 7.25M | n/a | 3.09M |
Other Current Assets | 2K | 7.31M | -1K | 8.73M | 1K | 8.67M | 2.17M | 8.18M | n/a | 4.28M | n/a | 5.54M |
Total Current Assets | 62.75M | 39.89M | 61.47M | 80.46M | 87.34M | 33.63M | 52.36M | 72.86M | 93.06M | 115.87M | 125.25M | 35.27M |
Property-Plant & Equipment | 4.57M | 4.61M | 5.54M | 5.75M | 6.25M | 6.48M | 7.12M | 7.41M | 8.19M | 7.54M | 8.26M | 8.96M |
Goodwill & Intangibles | 10K | 13K | 7K | 9K | 8K | 1K | 1K | 1K | 4K | 12K | 21K | 73K |
Total Long-Term Assets | 5.01M | 5.29M | 5.95M | 6.22M | 6.56M | 6.78M | 7.41M | 7.77M | 8.71M | 8.05M | 8.78M | 9.5M |
Total Assets | 67.76M | 45.17M | 67.42M | 86.68M | 93.9M | 40.41M | 59.77M | 80.62M | 101.77M | 123.92M | 134.03M | 44.77M |
Account Payables | 6.58M | 4.23M | 4.48M | 4.77M | 6.7M | 8.8M | 4M | 5.52M | 5M | 7.24M | 5.57M | 6.91M |
Deferred Revenue | 36.22M | n/a | 18.16M | n/a | 18.23M | 16.66M | 16.57M | 16.68M | 16.52M | 16.56M | 492K | n/a |
Short-Term Debt | 3.1M | 3.49M | 3.66M | 3.76M | 3.82M | 8.83M | 3.6M | 8M | 7.08M | 6.02M | 3.68M | 1.21M |
Other Current Liabilities | 430K | 40.79M | 8.27M | 26.56M | 8.56M | 17.65M | 7.41M | 18.45M | 17.34M | 17.69M | 815K | 5.88M |
Total Current Liabilities | 57.51M | 63.04M | 58.94M | 56.52M | 49.87M | 49.85M | 37.94M | 42.58M | 36.85M | 38.04M | 19.04M | 17.14M |
Long-Term Debt | 89.12M | 44.12M | 43.01M | 40.73M | 41.66M | 39.92M | 44.04M | 31.15M | 32.42M | 39.14M | 39.12M | 44.06M |
Other Long-Term Liabilities | 3.73M | 4.58M | 28.21M | 7.77M | 325K | 308K | 270K | 250K | 318K | 457K | 414K | 372K |
Total Long-Term Liabilities | 94.74M | 51.09M | 74.19M | 51.94M | 45.87M | 44.34M | 48.88M | 36.25M | 38.13M | 44.45M | 44.52M | 49.82M |
Total Liabilities | 152.24M | 114.13M | 133.12M | 108.46M | 95.74M | 94.19M | 86.81M | 78.83M | 74.98M | 82.48M | 63.56M | 66.96M |
Total Debt | 95.32M | 51.24M | 50.9M | 49.17M | 50.57M | 54M | 53.17M | 45.11M | 46.02M | 50.72M | 48.98M | 51.84M |
Book Value | -84.48M | -68.95M | -65.7M | -21.78M | -1.84M | -53.78M | -27.05M | 1.79M | 26.79M | 41.43M | 70.47M | -22.2M |
Book Value Per Share | -1.77 | -1.45 | -1.39 | -0.46 | -0.05 | -1.54 | -0.78 | 0.05 | 0.77 | 1.20 | 2.53 | -0.98 |
Common Stock | 1.45M | 1.45M | 1.42M | 1.42M | 1.41M | 1.06M | 1.05M | 1.05M | 1.05M | 1.05M | 1.03M | 682K |
Retained Earnings | -23.96M | -5.38M | -68.13M | -336.45M | -39.7M | -311.06M | -57.04M | -255.45M | -47M | -30.42M | -33.59M | -20.58M |
Comprehensive Income | -376.15M | -377.53M | -311.51M | 735K | -276.07M | -282.25M | -226.58M | 678K | -182.82M | -184.76M | -152.51M | -154.02M |
Shareholders Equity | -84.48M | -68.95M | -65.7M | -21.78M | -1.84M | -53.78M | -27.05M | 1.79M | 26.79M | 41.43M | 70.47M | -22.2M |
Total Investments | n/a | n/a | n/a | n/a | n/a | 1K | n/a | 352K | 98K | 88K | 105K | 58K |
Add to Watchlist
Select watchlists to add or remove NBTX